Subrtova K

From Bioblast
Revision as of 16:51, 22 May 2013 by Marte Verena (talk | contribs) (Created page with "{{Person |lastname= |firstname= |title= |Institution= |address= |Area Code= |City= |State / Province= |Country name= |mailaddress= |Weblink= }} {{labelingperson |Field of researc...")
(diff) ← Older revision | Latest revision (diff) | Newer revision β†’ (diff)
Name ,
Institution
Address ,
City
State/Province
Country
Email
Weblink
O2k-Network Lab


Labels:



Publications

 PublishedReference
Arbon 2022 Antimicrob Agents Chemother2022Arbon D, Ε½enΓ­Ε‘kovΓ‘ K, Ε ubrtovΓ‘ K, Mach J, Ε tursa J, Machado M, Zahedifard F, LeΕ‘tinovΓ‘ T, Hierro-Yap C, Neuzil J, Volf P, Ganter M, Zoltner M, ZΓ­kovΓ‘ A, Werner L, Sutak R (2022) Repurposing of MitoTam: Novel anti-cancer drug candidate exhibits potent activity against major protozoan and fungal pathogens. https://doi.org/10.1128/aac.00727-22
Hierro-Yap 2021 J Biol Chem2021Hierro-Yap C, Ε ubrtovΓ‘ K, Gahura O, Panicucci B, Dewar C, Chinopoulos C, Schnaufer A, ZΓ­kovΓ‘ A (2021) Bioenergetic consequences of FoF1-ATP synthase/ATPase deficiency in two life cycle stages of Trypanosoma brucei. J Biol Chem 296:100357.

Abstracts

 PublishedReference
Subrtova 2013 Abstract MiP20132013Subrtova K, Panicucci B, Zikova A (2013) Hypothetical Trypanosoma protein helps to anchor the F1ATPase moiety to the mitochondrial membrane. Mitochondr Physiol Network 18.08.
Cookies help us deliver our services. By using our services, you agree to our use of cookies.